[SCHEDULE 13G] Theratechnologies Inc. SEC Filing
Summer Road LLC filed a Schedule 13G reporting beneficial ownership of 2,683,591 Common Shares of Theratechnologies Inc. (CUSIP 88338H704), representing 5.84% of the 45,980,019 shares outstanding cited from the issuer's Form 20-F. The Reporting Person is a Delaware family office that holds these shares through investment management agreements with two Family Clients, identified as Cap 1 LLC and East River Partners Ltd. The filing states the shares are held passively and were not acquired to influence control of the issuer.
Summer Road LLC ha depositato un Schedule 13G che segnala la proprietà beneficiante di 2,683,591 azioni ordinarie di Theratechnologies Inc. (CUSIP 88338H704), che rappresentano 5,84% delle 45,980,019 azioni in circolazione citate nel modulo 20-F dell’emittente. La persona segnalante è un ufficio familiare del Delaware che detiene queste azioni tramite contratti di gestione degli investimenti con due Clienti Familiari, identificati come Cap 1 LLC e East River Partners Ltd.. La dichiarazione indica che le azioni sono detenute in modo passivo e non sono state acquisite per influenzare il controllo dell’emittente.
Summer Road LLC presentó un Schedule 13G informando la titularidad beneficiosa de 2,683,591 acciones ordinarias de Theratechnologies Inc. (CUSIP 88338H704), que representan 5,84% de las 45,980,019 acciones en circulación citadas en el Formulario 20-F del emisor. La Persona Reportante es una oficina familiar de Delaware que posee estas acciones a través de acuerdos de gestión de inversiones con dos Clientes Familiares, identificados como Cap 1 LLC y East River Partners Ltd.. La presentación indica que las acciones se mantienen de manera pasiva y no fueron adquiridas para influir en el control del emisor.
Summer Road LLC은 Theratechnologies Inc.의 유익 소유를 보고하는 Schedule 13G를 제출했습니다. 보유 주식 수는 2,683,591주(주식종류: 보통주)이며 CUSIP 88338H704에 해당하고, 이는 발행자의 Form 20-F에 명시된 45,980,019주 중 5.84%에 해당합니다. 보고인은 델라웨어 주의 패밀리 오피스로, 두 패밀리 고객인 Cap 1 LLC와 East River Partners Ltd.와의 자산 관리 계약을 통해 이 주식을 보유하고 있습니다. 이번 제출은 주식이 수동적으로 보유되었고 발행자의 지배력에 영향을 주기 위해 취득된 것이 아님을 명시합니다.
Summer Road LLC a déposé un Schedule 13G déclarant la propriété bénéficiaire de 2,683,591 actions ordinaires de Theratechnologies Inc. (CUSIP 88338H704), représentant 5,84% des 45,980,019 actions en circulation citées dans le formulaire 20-F de l’émetteur. La personne déclarante est un bureau familial du Delaware qui détient ces actions par le biais de accords de gestion d’investissements avec deux Clients Familiaux, identifiés comme Cap 1 LLC et East River Partners Ltd.. Le dépôt indique que les actions sont détenues passivement et n’ont pas été acquises pour influencer le contrôle de l’émetteur.
Summer Road LLC hat eine Schedule 13G eingereicht, in der die wirtschaftliche Eigentümerschaft an 2,683,591 Stammaktien von Theratechnologies Inc. (CUSIP 88338H704) gemeldet wird, was 5,84% der 45,980,019 ausstehenden Aktien entspricht, die im Emittentenformular 20-F angegeben sind. Die meldende Person ist ein Family Office mit Sitz in Delaware, das diese Aktien durch Investment-Management-Vereinbarungen mit zwei Family Clients hält, identifiziert als Cap 1 LLC und East River Partners Ltd.. Die Einreichung besagt, dass die Aktien passiv gehalten werden und nicht erworben wurden, um die Kontrolle über den Emittenten zu beeinflussen.
Summer Road LLC قد قدمت Schedule 13G تفيد بالملكية المنفعة لـ 2,683,591 سهماً عاديًا من Theratechnologies Inc. (CU SIP 88338H704)، مما يمثل 5.84% من 45,980,019 سهماً قائماً كما ورد في نموذج الشركة 20-F. الشخص المبلغ عنه هو مكتب عائلي في ديلاوير يمتلك هذه الأسهم من خلال اتفاقيات إدارة الاستثمار مع عميلين عائليين، هما Cap 1 LLC و East River Partners Ltd. تنص الإيداع على أن الأسهم مملوكة بشكل سلبي ولم تُكتسب لإحداث التأثير على السيطرة على الجهة المصدرة.
Summer Road LLC 已提交 Schedule 13G,报告 Theratechnologies Inc. 的实际受益所有权,持有 2,683,591 股普通股(CUSIP 88338H704),占发行人披露的 45,980,019 股在外流通股本的 5.84%。 本报告人是位于特拉华州的家族办公室,通过与两位家族客户的资产管理协议持有这些股票,分别为 Cap 1 LLC 与 East River Partners Ltd.。 文件中称这些股份为被动持有,并未为影响发行人的控制权而取得。
- Transparent disclosure of a material 5.84% stake (2,683,591 shares)
- Identification of underlying holders (Cap 1 LLC and East River Partners Ltd.) improves investor clarity
- Reporting Person states passive intent, reducing immediate governance/activism concerns
- None.
Insights
TL;DR: A family office reports a passive stake of 5.84% in Theratechnologies, disclosing beneficial owners and voting/dispositive power.
The Schedule 13G shows Summer Road LLC controls 2,683,591 shares with sole voting and dispositive power, indicating consolidated management of these holdings through IMAs with Family Clients. Disclosure under Rule 13d-1(c) signals a passive intent rather than an activist stance, which typically reduces near-term governance risk for existing management while creating a meaningful minority ownership position that could attract investor attention.
TL;DR: Material passive ownership disclosed; names of underlying family clients are provided for transparency.
The filing identifies the Reporting Person as a family office operating under the Family Office Rule and names two Family Clients holding the shares. This level of disclosure improves transparency about who holds a material stake (>5%) and clarifies that voting/dispositive authority rests with the Reporting Person, which is relevant for governance monitoring but does not indicate an intent to change control.
Summer Road LLC ha depositato un Schedule 13G che segnala la proprietà beneficiante di 2,683,591 azioni ordinarie di Theratechnologies Inc. (CUSIP 88338H704), che rappresentano 5,84% delle 45,980,019 azioni in circolazione citate nel modulo 20-F dell’emittente. La persona segnalante è un ufficio familiare del Delaware che detiene queste azioni tramite contratti di gestione degli investimenti con due Clienti Familiari, identificati come Cap 1 LLC e East River Partners Ltd.. La dichiarazione indica che le azioni sono detenute in modo passivo e non sono state acquisite per influenzare il controllo dell’emittente.
Summer Road LLC presentó un Schedule 13G informando la titularidad beneficiosa de 2,683,591 acciones ordinarias de Theratechnologies Inc. (CUSIP 88338H704), que representan 5,84% de las 45,980,019 acciones en circulación citadas en el Formulario 20-F del emisor. La Persona Reportante es una oficina familiar de Delaware que posee estas acciones a través de acuerdos de gestión de inversiones con dos Clientes Familiares, identificados como Cap 1 LLC y East River Partners Ltd.. La presentación indica que las acciones se mantienen de manera pasiva y no fueron adquiridas para influir en el control del emisor.
Summer Road LLC은 Theratechnologies Inc.의 유익 소유를 보고하는 Schedule 13G를 제출했습니다. 보유 주식 수는 2,683,591주(주식종류: 보통주)이며 CUSIP 88338H704에 해당하고, 이는 발행자의 Form 20-F에 명시된 45,980,019주 중 5.84%에 해당합니다. 보고인은 델라웨어 주의 패밀리 오피스로, 두 패밀리 고객인 Cap 1 LLC와 East River Partners Ltd.와의 자산 관리 계약을 통해 이 주식을 보유하고 있습니다. 이번 제출은 주식이 수동적으로 보유되었고 발행자의 지배력에 영향을 주기 위해 취득된 것이 아님을 명시합니다.
Summer Road LLC a déposé un Schedule 13G déclarant la propriété bénéficiaire de 2,683,591 actions ordinaires de Theratechnologies Inc. (CUSIP 88338H704), représentant 5,84% des 45,980,019 actions en circulation citées dans le formulaire 20-F de l’émetteur. La personne déclarante est un bureau familial du Delaware qui détient ces actions par le biais de accords de gestion d’investissements avec deux Clients Familiaux, identifiés comme Cap 1 LLC et East River Partners Ltd.. Le dépôt indique que les actions sont détenues passivement et n’ont pas été acquises pour influencer le contrôle de l’émetteur.
Summer Road LLC hat eine Schedule 13G eingereicht, in der die wirtschaftliche Eigentümerschaft an 2,683,591 Stammaktien von Theratechnologies Inc. (CUSIP 88338H704) gemeldet wird, was 5,84% der 45,980,019 ausstehenden Aktien entspricht, die im Emittentenformular 20-F angegeben sind. Die meldende Person ist ein Family Office mit Sitz in Delaware, das diese Aktien durch Investment-Management-Vereinbarungen mit zwei Family Clients hält, identifiziert als Cap 1 LLC und East River Partners Ltd.. Die Einreichung besagt, dass die Aktien passiv gehalten werden und nicht erworben wurden, um die Kontrolle über den Emittenten zu beeinflussen.